Quadrant Capital Group’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$590K Buy
25,992
+1,764
+7% +$40.4K 0.02% 808
2026
Q1
$565K Buy
24,228
+715
+3% +$15.4K 0.02% 848
2025
Q4
$470K Buy
23,513
+938
+4% +$18.3K 0.01% 946
2025
Q3
$412K Sell
22,575
-76
-0.3% -$1.48K 0.01% 971
2025
Q2
$455K Buy
22,651
+1,130
+5% +$21.7K 0.02% 930
2025
Q1
$390K Buy
21,521
+12,564
+140% +$225K 0.01% 910
2024
Q4
$155K Hold
8,957
0.01% 818
2024
Q3
$173K Sell
8,957
-64
-0.7% -$1.18K 0.01% 775
2024
Q2
$148K Sell
9,021
-287
-3% -$4.45K 0.01% 802
2024
Q1
$142K Buy
9,308
+266
+3% +$4.18K 0.01% 817
2023
Q4
$145K Buy
9,042
+1,056
+13% +$14.8K 0.01% 784
2023
Q3
$104K Sell
7,986
-183
-2% -$2.38K 0.01% 845
2023
Q2
$104K Buy
8,169
+2,719
+50% +$34K 0.01% 848
2023
Q1
$61.3K Buy
5,450
+2,742
+101% +$33.3K 0.01% 1113
2022
Q4
$35.9K Buy
2,708
+543
+25% +$7.14K ﹤0.01% 1369
2022
Q3
$25K Buy
2,165
+2,079
+2,417% +$28.5K ﹤0.01% 1434
2022
Q2
$1K Sell
86
-104
-55% -$1.7K ﹤0.01% 2380
2022
Q1
$4K Buy
190
+126
+197% +$2.25K ﹤0.01% 1974
2021
Q4
$1K Hold
64
﹤0.01% 2320
2021
Q3
$1K Buy
64
+16
+33% +$239 ﹤0.01% 2324
2021
Q2
$1K Buy
48
+10
+26% +$125 ﹤0.01% 2281
2021
Q1
$0 Buy
+38
New +$459 ﹤0.01% 2419
2020
Q4
Sell
-45
Closed 2334
2020
Q3
$0 Sell
45
-17
-27% -$216 ﹤0.01% 2232
2020
Q2
$1K Hold
62
﹤0.01% 2071
2020
Q1
$1K Buy
+62
New +$820 ﹤0.01% 1996
2019
Q3
Sell
-1,929
Closed -$28K 2341
2019
Q2
$28K Hold
1,929
﹤0.01% 1491
2019
Q1
$27K Buy
+1,929
New +$31.2K ﹤0.01% 1435

Other funds holding INVA

Quadrant Capital Group's INVA Position: Q2 2026 in Review

Quadrant Capital Group increased its Innoviva (INVA) stake by 7.3% in Q2 2026, buying an estimated $40.4K and bringing the position to 25,992 shares worth $590K. The position accounts for 0.02% of the portfolio, ranked #808.

Quadrant Capital Group first reported a position in INVA in Q1 2019 and has held it in 27 quarters since. 308 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • Quadrant Capital Group held 25,992 shares of Innoviva worth $590K as of Q2 2026.
  • Quadrant Capital Group bought 1,764 Innoviva shares in Q2 2026, an estimated $40.4K.
  • Innoviva made up 0.02% of Quadrant Capital Group's portfolio in Q2 2026, its #808 holding.
  • Quadrant Capital Group first reported a position in Innoviva in Q1 2019 and has held it in 27 quarters since.
  • 308 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.